Send us a link
When India’s 1.3 billion people come out of a 40-day lockdown on 3 May, imposed to contain the spread of COVID-19, they can hope that a battery of technologies that the government is readying to deploy against the contagious virus could offer them some protection.
Only one species is responsible for coronavirus - humans - say world's leading wildlife experts.
In recent months, claims with some scientific legitimacy have spread so far, so fast, that even if it later becomes clear they are false or unfounded, they cannot be laid to rest.
Target audience are healthcare professionals from all specialities.
Paving the way for the future through research.
The scientific community must take up cudgels in the battle against bunk.
Global leaders have pledged to accelerate cooperation on a coronavirus vaccine and to share research, treatment and medicines across the globe. But the United States did not take part.
Scholarly publishers are working together to maximize the efficiency of peer review, ensuring that key work related to COVID-19 is reviewed and published as quickly and openly as possible. The group of publishers and scholarly communications organizations - initially comprising eLife, Hindawi, PeerJ, PLOS, Royal Society, F1000 Research, FAIRsharing, Outbreak Science, and PREreview - is... Read full article >
The new and improved Times Higher Education (THE) Impact Rankings 2020 were published this week with as much online fanfare as THE could muster. Unfortunately,
Many outside observers might reasonably assume that science usually works like this. Yet open science is very far from the norm for most research. Why is openly accessible science so important?
It won't be easy, but there's a path to get students back on track. Higher education will crumble without it.
Data sharing, open-source designs for medical equipment, and hobbyists are all being harnessed to combat COVID-19.
Editors of academic journals have started noticing a trend: Women - who inevitably shoulder a greater share of family responsibilities - seem to be submitting fewer papers, while men are submitting up to 50 percent more than they usually would.
The American Physical Society held its massive April Meeting online because of coronavirus - and registrations soared.
The European Commission is working on an investment plan to fuel the EU’s recovery from the Covid-19 pandemic, which Commission president Ursula von der Leyen has said must increase the “firepower” of the bloc’s 2021-27 budget, and R&D commissioner Mariya Gabriel has said must prioritise investment in R&D.
For Elizabeth Gadd, the Covid-19 pandemic makes it clear that long standing issues with academic publications need to be addressed quickly and definitively.
A public forum for researchers to discuss the science of science, current events, and science policy issues.
Many initiatives are keeping track of research on COVID-19 and coronaviruses. These initiatives, while valuable because they allow for fast access to relevant research, pose the question of subject delineation. We analyse here one such initiative, the COVID-19 Open Research Dataset (CORD-19).
The study replicates the NIPS experiment of 2014, showing that the ratings of peer review are not robust, and that altering reviewers leads to a dramatic impact on the ranking of the papers. This paper also shows that innovative works are not highly ranked in the existing peer review process, and in consequence are often rejected.
Early journal submission data suggest COVID-19 is tanking women's research productivity.
Anders Tegnell talks to Nature about the nation's 'trust-based' approach to tackling the pandemic.
Secure contact tracing could be a powerful tool to fight the spread of COVID-19. A unique, decentralized system developed as part of an international consortium, including EPFL and ETH Zurich, will soon be launched with the support of the Swiss Federal Office of Public Health.
Nassim Nicholas Taleb is frustrated whenever the coronavirus crisis is referred to by the term he coined for an unpredictable, rare catastrophe.
Researchers believe they could pre-emptively create vaccines and drugs to fight a wide range of viral threats - if they can get sufficient funding.
Atma Ivancevic shares what keeps her passionate about science when academic work gets tough, and while working from home.
